Monotherapy or in combination w/ tamsulosin for treatment & control of symptomatic benign prostatic hyperplasia (BPH) in men w/ enlarged prostate to improve symptoms, reduce the risk of acute urinary retention & the need for BPH-related surgery.
Monitor for obstructive uropathy in patients w/ large residual urinary vol &/or severely diminished urinary flow. Perform digital rectal exam & serum prostate-specific antigen level for prostate cancer detection. Changes in breast tissue eg, lumps or nipple discharge; male breast cancer. Avoid donating blood until at least 6 mth after last dose. Combination therapy w/ α-blocker. Mild to moderate hepatic impairment. Avoid use in women, childn & adolescents. Pregnancy or potential pregnancy.